NASDAQ: GNCA       Genocea Biosciences
Last Price Today's Change   Day's Range   Trading Volume
2.26   +0.02 (0.89%)  2.21 - 2.29  22,266


Avg Volume (4 weeks):242,915
4 Weeks Range:2.15 - 2.75
4 Weeks Price Volatility (%):
52 Weeks Range:1.10 - 5.75
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Genocea Biosciences Inc is a US-based biopharmaceutical company which is engaged in developing novel vaccines and immunotherapies to address diseases with significant unmet needs. Its product candidate includes GEN-003 which is an immunotherapy for the treatment of genital herpes as well as it owns pre-clinical immuno-oncology program focused on personalized cancer vaccines. The company focuses on developing vaccines and immunotherapies for unmet needs through its AnTigen Lead Acquisition System, which is used to design vaccines and immunotherapies. Genocea operates its business through the single segment being Developing and Commercializing vaccines.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

2265  3509  469  3145 

Top 10 Active Counters
 LK 1.38+1.38 
 ISIG 1.38+0.434 
 OAS 0.155-0.014 
 AMD 79.135-3.095 
 NIO 27.492+1.482 
 AMTD 39.97-0.85 
 PGNX 4.10-0.425 
 XOG 0.271-0.062 
 AAPL 116.202+1.152 
 SNAP 41.89+0.62